EPM speaks to Jean-Pierre Joubert, product manager at CN Bio Innovations who talks about his journey into biotech, the challenges of drug development, and why opportunities come from unlikely places.
EPM sits down with Scott Ross, global product specialist for the GORE LYOGUARD Freeze-Drying Trays, to learn about lyophilsation in API manufacturing and the benefits of single-use products.
The role AI can play in drug discovery and development is well documented, but the recent global pandemic has highlighted the growing importance this technology has in the fight against disease, writes Lu Rahman.
EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.
Dr Peter Jackson, executive director of the AMR Centre explains why a new clinical trial taking place in the UK could represent a major step forward in the fight against antimicrobial resistance (AMR).
Maurits Lugard, Dr. Dorothee Schramm, and Anna-Shari Melin from law firm Sidley & Austin explain how pharmaceutical companies with products on the EU market can address product shortages and supply chain issues in the current Covid-19 crisis.
As the Covid-19 pandemic continues, pharmaceutical companies are taking generous steps and removing intellectual property rights for many key drugs which could help fight the virus.
